Revealing/VBG Adverse/JJ Drug/NN Reactions/NNS (/-LRB- ADR/NN )/-RRB- is/VBZ an/DT essential/JJ part/NN of/IN post-marketing/JJ drug/NN surveillance/NN ,/, and/CC data/NNS from/IN health/NN -/HYPH related/VBN forums/NNS and/CC medical/JJ communities/NNS can/MD be/VB of/IN a/DT great/JJ significance/NN for/IN estimating/VBG such/JJ effects/NNS ./.
In/IN this/DT paper/NN ,/, we/PRP propose/VBP an/DT end/NN -/HYPH to/IN -/HYPH end/NN CNN/NNP -/HYPH based/VBN method/NN for/IN predicting/VBG drug/NN safety/NN on/IN user/NN comments/NNS from/IN healthcare/NN discussion/NN forums/NNS ./.
We/PRP present/VBP an/DT architecture/NN that/WDT is/VBZ based/VBN on/IN a/DT vast/JJ ensemble/NN of/IN CNNs/NNS with/IN varied/JJ structural/JJ parameters/NNS ,/, where/WRB the/DT prediction/NN is/VBZ determined/VBN by/IN the/DT majority/NN vote/NN ./.
To/TO evaluate/VB the/DT performance/NN of/IN the/DT proposed/VBN solution/NN ,/, we/PRP present/VBP a/DT large/JJ -/HYPH scale/NN dataset/NN collected/VBN from/IN a/DT medical/JJ website/NN that/WDT consists/VBZ of/IN over/IN 50/CD thousand/CD reviews/NNS for/IN more/JJR than/IN 4000/CD drugs/NNS ./.
The/DT results/NNS demonstrate/VBP that/IN our/PRP$ model/NN significantly/RB outperforms/VBZ conventional/JJ approaches/NNS and/CC predicts/VBZ medicine/NN safety/NN with/IN an/DT accuracy/NN of/IN 87.17/CD percent/NN for/IN binary/JJ and/CC 62.88/CD percent/NN for/IN multi-classification/NN tasks/NNS ./.
